NCT06789185 is a NA clinical trial of 0.1mg/kg esketamine in Inguinal Hernia, sponsored by Qiu jinpeng.

Who is sponsoring NCT06789185?

NCT06789185 is sponsored by Qiu jinpeng.

What drugs are being tested in NCT06789185?

Interventions in NCT06789185: 0.1mg/kg esketamine, 0.2mg/kg esketamine, 0.1ml/kg normal saline.

What condition does NCT06789185 study?

NCT06789185 studies Inguinal Hernia.

Is NCT06789185 still recruiting?

NCT06789185 is currently completed. Last updated 22 May 2025.

Last reviewed 2025-05-22 · How we verify

NCT06789185

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effects of Esketamine at Subanesthetic Dose on Emergence Delirium in Preschool Children Undergoing Ambulatory Laparoscopic Surgery

Completed NA Last updated 22 May 2025

What this trial tests

NA trial testing 0.1mg/kg esketamine in Inguinal Hernia in 96 participants. Completed in 16 May 2025.

Timeline

7 February 2025

Primary endpoint
16 May 2025

16 May 2025

Quick facts

Lead sponsor	Qiu jinpeng
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	quadruple
Primary purpose	prevention
Enrollment	96
Start date	7 February 2025
Primary completion	16 May 2025
Estimated completion	16 May 2025
Sites	1 location across China

Drugs / interventions tested

0.1mg/kg esketamine — full drug profile →
0.2mg/kg esketamine — full drug profile →
0.1ml/kg normal saline — full drug profile →

Conditions studied

Inguinal Hernia — all drugs for Inguinal Hernia →

Sponsor

Qiu jinpeng — full company profile →

Who can join

Adults 24 Months to 71 Months, any sex, with Inguinal Hernia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Emergence delirium (ED) is a manifestation of acute postoperative brain dysfunction that occurs with a relatively high frequency after pediatric anesthesia. The incidence varies depending on the diagnostic criteria used and the combination of administered anesthetic drugs. The goal of this clinical trial is to investigate whether a subanesthetic dose of esketamine can reduce incidence of ED.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Inguinal Hernia

Currently open trials in the same condition.

NCT07473687 — Feasibility Study of Non-Contact Imaging-Based Physiological Monitoring in the Operating Room · recruiting
NCT06915155 — Swing-Mesh™ Study (SMS). · active not recruiting
NCT07346742 — Prevention of Surgical Site Infection in Open Paediatric Groin Surgeries Using Intravenous Prophylactic Antibiotics and · NA · recruiting
NCT06871605 — Transversalis Fascia Plane vs Ilioinguinal and Iliohypogastric Nerve Block for the Treatment of CPIP · NA · recruiting
NCT04706026 — A Pilot Study of Local Anesthesia for Inguinal Hernia Surgery in Older Adults · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06789185 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Qiu jinpeng
Last refreshed: 22 May 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06789185.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing